Idenix Pharma downgraded to "market perform"
09/08/10 - JMP Securities
NEW YORK, September 8 (newratings.com) - Analysts at JMP Securities downgrade Idenix Pharma (IDIX) from "market outperform" to "market perform."
Share Recommend this article to a friend add IDIX to my stocks and get e-mail alerts on Idenix Pharmaceuticals
|07/14/10||Idenix Pharmaceuticals initiated with "buy"||Stifel Nicolaus|
|10/30/09||Idenix Pharma downgraded to "above average"||Caris & Company|
|10/21/09||Idenix Pharma initiated with "outperform"||Wedbush Morgan Securities|